Acute Fatty Liver of Pregnancy

Acute Fatty Liver of Pregnancy is a rare, life-threatening liver problem that usually appears late in pregnancy (third trimester) or in the early days after delivery. Tiny fat droplets build up inside liver cells (called micro-vesicular steatosis). As fat fills the cells, the liver cannot do its normal jobs: making clotting factors, controlling blood sugar, clearing toxins like ammonia, and balancing fluid and salts. This failure can move quickly and cause low blood sugar, confusion (encephalopathy), bleeding, kidney injury, and infection. The most accepted trigger is a problem in how long-chain fats are broken down in mitochondria, often linked to a fetal enzyme issue called LCHAD deficiency; many mothers are healthy carriers, and when the fetus has the defect, toxic fat by-products spill over and stress the mother’s liver. The condition is an obstetric emergency: once suspected, the safest and most effective treatment is prompt delivery plus intensive supportive care. Most mothers recover within days after delivery when care is rapid. NCBI+1cme.lww.com

Acute fatty liver of pregnancy is a rare, serious liver problem that happens most often in the last 3 months of pregnancy or just after delivery. In this condition, tiny droplets of fat build up inside the liver cells. This fat changes how the liver works. The liver cannot do its normal jobs well, like clearing toxins, making clotting proteins, controlling sugar, and balancing body fluids. Because the liver is central to many body systems, the problem can spread quickly to the blood, kidneys, brain, and lungs. Without fast care and delivery of the baby, the mother and baby can get very sick. With early recognition, careful monitoring, and timely delivery, most mothers and babies recover.

How it happens

During late pregnancy, the mother’s body burns more fat for energy. In some pregnancies, the baby has a gene problem that blocks normal fat breakdown (fatty-acid oxidation). The baby’s placenta sends partially processed fat by-products back to the mother. These by-products are toxic to the mother’s liver and build up as tiny fat droplets inside liver cells (called “microvesicular steatosis”). The stressed liver then struggles to handle sugar, clotting, and detox duties. Blood sugar can drop, blood cannot clot well, toxins rise, and kidneys may fail. Swelling, confusion, and breathing problems can develop. Because this can change hour by hour, doctors treat it as an emergency and usually plan prompt delivery once the diagnosis is likely.

Other names

Acute fatty liver of pregnancy is also called acute microvesicular steatosis of pregnancy, gestational acute fatty liver, pregnancy-related acute liver failure, acute hepatic fatty infiltration of pregnancy, and acute gestational liver failure due to microvesicular steatosis. Older writings may say Reye-like hepatic failure of pregnancy, because the liver changes look similar to Reye syndrome under the microscope (tiny fat droplets inside cells). Some clinicians simply shorten it to AFLP. You may also see maternal liver failure of pregnancy or pregnancy-associated microvesicular steatosis. All these names describe the same core problem: fast-onset liver injury in late pregnancy caused by micro-fat deposits inside liver cells.

Types

1. Typical third-trimester AFLP. The most common pattern. Symptoms start around weeks 32–38 with nausea, vomiting, and right-upper-belly pain, then jaundice.

2. Early-onset AFLP. Less common. Starts in the second trimester. The biology is similar but begins sooner.

3. Postpartum AFLP. Symptoms begin only after birth, often within a few days.

4. AFLP overlapping with preeclampsia/HELLP. Some patients show features of both conditions at the same time (high blood pressure, protein in urine, low platelets) together with AFLP changes.

5. Genetic/FAO-linked AFLP. Clear history or testing ties the case to a fetal fatty-acid oxidation (FAO) disorder (for example, LCHAD deficiency).

6. Severity-based (mild, moderate, severe). Doctors sometimes use a practical scale based on sugar level, clotting problems, kidney injury, and brain symptoms.

---

Causes

Note: AFLP is usually not caused by one single thing. It happens when late-pregnancy metabolism meets genetic and placental factors. Items below explain known drivers and strong associations.

1. Fetal LCHAD deficiency (HADHA gene). A baby with this fatty-acid oxidation defect sends harmful fat by-products to the mother, stressing her liver.

2. Fetal mitochondrial trifunctional protein defects (HADHA/HADHB variants beyond LCHAD). Similar pathway; incomplete fat breakdown leads to maternal liver toxicity.

3. Other fetal FAO disorders (e.g., VLCAD deficiency). Very-long-chain fat breakdown problems can produce toxic intermediates that reach the mother.

4. Fetal MCAD deficiency. Medium-chain fat processing is blocked, increasing toxic metabolites that the placenta returns to the mother.

5. Fetal CPT-II deficiency or carnitine cycle defects. If long-chain fats cannot enter mitochondria, by-products accumulate and spill back to the mother.

6. Maternal carrier status for FAO defects. Mothers who carry certain variants may be more vulnerable to liver stress when exposed to fetal metabolites.

7. Placental mitochondrial stress. A stressed placenta releases more lipid intermediates and inflammatory signals, burdening the maternal liver.

8. Multiple gestation (twins/triplets). More placental mass means more fatty-acid flux and higher metabolite load to the mother.

9. Male fetus (association). Studies have found a male fetus more often in AFLP, likely reflecting certain genetic patterns.

10. First pregnancy (nulliparity). The first pregnancy sometimes shows a higher risk, possibly due to immune and metabolic adaptation being “new.”

11. Family history of AFLP or infants with FAO disorders. Suggests inherited risks for defects that disturb fat handling.

12. Late-pregnancy insulin resistance. Normal insulin resistance rises in the third trimester; this increases fat use and by-product generation.

13. Maternal under-nutrition or prolonged fasting. Lack of fuel shifts the body to burn more fat, increasing toxic intermediates.

14. Severe or persistent vomiting (hyperemesis). Starvation and ketone production further push fat metabolism, stressing the liver.

15. Overlap with preeclampsia/HELLP. These conditions amplify endothelial injury and inflammation, worsening liver vulnerability.

16. Medications with mitochondrial toxicity (e.g., valproate, high-dose tetracycline). Rare in pregnancy but can add liver stress if present.

17. Acute infections that strain the liver (e.g., sepsis). Not direct causes of AFLP, but they lower liver reserve and unmask failure.

18. Low maternal carnitine. Carnitine moves fats into mitochondria; deficiency can slow fat processing and raise toxic intermediates.

19. Oxidative stress states (e.g., uncontrolled thyroid disease or severe anemia). Extra oxidative load makes liver cells more fragile.

20. Environmental toxin exposure (rare, e.g., aflatoxins). Toxins can impair mitochondria and magnify pregnancy-related fat stress.

---

Symptoms

1. Nausea. A common early sign; food smells may worsen it.

2. Vomiting. Often follows nausea and limits fluid and calorie intake.

3. Loss of appetite. Patients “just cannot eat,” which increases fat burning and can worsen the problem.

4. Tiredness and body weakness. The liver cannot supply steady energy, and toxins make you feel unwell.

5. Pain in the right-upper belly or the middle above the stomach. The liver capsule becomes sensitive when the liver is inflamed or swollen.

6. Jaundice (yellow eyes/skin). The liver cannot clear bilirubin well, so it builds up.

7. Itching. Bile salts may rise in the skin and cause itch.

8. Headache. May result from overall illness or from overlap with high blood pressure conditions.

9. Excessive thirst and frequent urination. Can reflect sugar imbalance or kidney involvement.

10. Confusion, sleepiness, or agitation. Toxins such as ammonia affect brain function (hepatic encephalopathy).

11. Easy bruising or bleeding gums. The liver makes clotting proteins; when low, bleeding risk rises.

12. Dark urine and pale stools. Bilirubin spills into urine; less bile reaches the intestines.

13. Swollen legs or sudden weight gain. Fluid can leak into tissues when proteins and hormones are off-balance.

14. Shortness of breath. Fluid in the lungs or severe anemia can make breathing harder.

15. Fever or chills (sometimes). Not typical of AFLP itself but can occur with infection or inflammation.

---

Diagnostic Tests

Physical Exam

1. Vital signs check (blood pressure, heart rate, temperature, oxygen). High blood pressure suggests preeclampsia overlap; fever points to infection; fast heart rate and low oxygen signal stress.

2. Skin and eye exam for jaundice. Yellow color shows bilirubin buildup. Doctors also look for bruises and tiny bleeding spots.

3. Abdominal exam. Gentle pressing over the right-upper belly checks for liver tenderness or swelling and looks for fluid (a “full” feeling).

4. Basic neurologic exam. The clinician checks alertness, orientation, and behavior to spot early brain effects from liver toxins.

Manual Tests (bedside maneuvers)

5. Asterixis (“liver flap”) test. With arms out and wrists extended, brief flapping suggests encephalopathy from liver failure.

6. Shifting dullness for ascites. Tapping the belly while you roll to one side helps detect free fluid, which can occur in severe disease.

7. Murphy sign (to compare with gallbladder disease). Pain on a deep breath under the right rib can point to gallbladder problems; a negative test can support looking beyond gallstones to AFLP.

8. Skin turgor and capillary refill. A quick check for dehydration from vomiting; dehydration worsens kidney stress in AFLP.

Lab and Pathological Tests

9. Liver enzymes (ALT, AST). Usually moderately elevated in AFLP (often lower than in viral hepatitis); they show liver injury level.

10. Bilirubin (total/direct). Elevated levels explain jaundice and help track severity.

11. Coagulation studies (PT/INR, aPTT) and fibrinogen. The liver makes clotting factors; prolonged times and low fibrinogen warn of bleeding risk.

12. Blood glucose. Low sugar (hypoglycemia) is a red flag, because the injured liver cannot release enough glucose.

13. Complete blood count. Platelets may be low; white cells may be high; anemia may appear with bleeding or dilution.

14. Kidney function (creatinine, BUN). Rising numbers show kidney stress or failure, which can occur with AFLP.

15. Uric acid and LDH. High levels support overlap with preeclampsia/HELLP and point to cell injury and oxidation stress.

16. Liver biopsy (rarely needed). Under a microscope, the classic look is “microvesicular steatosis” (many tiny fat droplets in liver cells). Because bleeding risk is high, this test is used only when essential.

Electrodiagnostic Tests

17. Electrocardiogram (ECG). Checks heart rhythm changes due to electrolyte shifts (like high potassium) or low oxygen; helps guide safe care.

18. Electroencephalogram (EEG). In marked confusion or seizures, EEG can show diffuse brain slowing from liver-related toxins and exclude other causes.

Imaging Tests

19. Right-upper-quadrant ultrasound (liver and gallbladder). Safe in pregnancy; looks for other causes (gallstones, bile blockage) and may show a bright-looking liver, though imaging can be normal in AFLP.

20. MRI of the liver (without gadolinium). More sensitive than ultrasound for fat in the liver and inflammation; avoids radiation and gives useful detail in complex cases.

Non-Pharmacological Treatments

Important: In AFLP, the cornerstone is prompt delivery and intensive supportive care in hospital/ICU. The following items explain supportive, non-drug measures used alongside medical therapy. Each item lists Description, Purpose, Mechanism, Benefits in plain English.

A. Physiotherapy-focused

1. Head-up positioning (30–45°)
   Description: Keep the upper body elevated in bed.
   Purpose: Reduce risk of aspiration; help breathing when fluid shifts affect lungs.
   Mechanism: Uses gravity to lower pressure on the diaphragm and reduce reflux.
   Benefits: Easier breathing, less aspiration risk during nausea/vomiting.

2. Diaphragmatic breathing practice
   Purpose: Improve oxygen flow and calm anxiety.
   Mechanism: Slow deep breaths improve ventilation and can lower sympathetic stress.
   Benefits: May reduce shortness of breath and improve comfort.

3. Incentive spirometry coaching
   Purpose: Keep small airways open in a patient spending time in bed.
   Mechanism: Encourages regular lung expansion.
   Benefits: Lowers atelectasis risk and related pneumonia risk in prolonged hospitalization.

4. Gentle limb range-of-motion (ROM)
   Purpose: Maintain joint mobility during bed rest.
   Mechanism: Moves joints safely without over-exertion.
   Benefits: Prevents stiffness and reduces DVT risk when coupled with compression.

5. Early, supervised mobilization (post-stabilization)
   Purpose: Regain function after delivery/ICU.
   Mechanism: Short, guided walks with monitoring.
   Benefits: Better circulation, lung function, and mood.

6. Bedside cough-assist/airway clearance techniques
   Purpose: Clear secretions if weak or sedated.
   Mechanism: Physiotherapy maneuvers and splinting with a pillow.
   Benefits: Fewer respiratory complications.

7. Pelvic floor awareness (postpartum)
   Purpose: Early rehab that is gentle and safe.
   Mechanism: Light activation cues; no straining.
   Benefits: Supports pelvic recovery without stressing the abdomen.

8. Safe transfer training
   Purpose: Prevent falls and bleeding in coagulopathy.
   Mechanism: Teach log-roll, use of rails; supervised standing.
   Benefits: Safety and confidence.

9. Edema management with limb elevation
   Purpose: Reduce swelling from fluid shifts.
   Mechanism: Elevation assists venous/lymphatic return.
   Benefits: Comfort and mobility.

10. Compression stockings (if not contraindicated)
    Purpose: DVT prevention during low mobility.
    Mechanism: Graduated pressure supports venous return.
    Benefits: Lower clot risk; complements medical DVT prophylaxis.

11. Activity pacing & energy conservation
    Purpose: Manage fatigue during recovery.
    Mechanism: Short activity blocks + rest.
    Benefits: Gradual stamina gains without setbacks.

12. Posture coaching for reflux/nausea
    Purpose: Ease GI symptoms common in AFLP.
    Mechanism: Upright posture after meals; avoid bending.
    Benefits: Less heartburn and vomiting episodes.

13. Abdominal binder (case-by-case)
    Purpose: Comfort and support after C-section.
    Mechanism: Gentle external support to abdominal wall.
    Benefits: Reduced pain → easier breathing/mobilization.

14. Safe cough/sneeze “splinting”
    Purpose: Reduce pain at incision and lower bleeding stress.
    Mechanism: Press pillow against abdomen when coughing.
    Benefits: Better airway clearance with less discomfort.

15. Guided, very light stretching
    Purpose: Relieve muscle tension from bed rest.
    Mechanism: Short, pain-free holds.
    Benefits: Comfort, sleep quality.

B. Mind-Body / Gene-Informed Counseling / Educational Therapy

16. Simple mindfulness (5-minute breath focus)
    Purpose: Ease fear and post-ICU stress.
    Mechanism: Trains attention away from rumination.
    Benefits: Lower perceived pain/anxiety; better sleep.

17. Coping-skills coaching for the partner
    Purpose: Build a safe home environment post-discharge.
    Mechanism: Teach red-flags, medication times, and emergency plans.
    Benefits: Faster help if symptoms recur.

18. Trauma-informed debrief after ICU
    Purpose: Reduce PTSD-like symptoms common after critical illness.
    Mechanism: Structured review of what happened, validation, and supports.
    Benefits: Better mental health and adherence.

19. Nutrition teaching for recovery
    Purpose: Explain small, frequent meals; adequate protein; hydration.
    Mechanism: Stepwise refeeding with thiamine support if needed.
    Benefits: Steadier blood sugar and energy.

20. Sleep hygiene routine
    Purpose: Restore circadian rhythm after ICU nights.
    Mechanism: Light control, regular bed/wake times.
    Benefits: Improved mood, immune function.

21. Gene-aware counseling (FAO defects like LCHAD)
    Purpose: Explain why screening and genetic counseling matter for future pregnancies.
    Mechanism: Discuss carrier testing and partner/fetal testing options.
    Benefits: Informed planning and risk reduction. PMC

22. Alcohol and herbal-supplement avoidance education
    Purpose: Protect recovering liver.
    Mechanism: Remove hepatotoxins and unregulated herbs.
    Benefits: Prevent setbacks.

23. Glycemia self-monitoring education (if advised)
    Purpose: Detect low sugars early during recovery.
    Mechanism: Teach finger-stick technique, hypoglycemia plan.
    Benefits: Safety and confidence.

24. Medication literacy
    Purpose: Know why each medicine is used and for how long.
    Mechanism: One-page, plain-language list.
    Benefits: Better adherence; prevents double-dosing.

25. Emergency action plan card
    Purpose: Quick steps if severe abdominal pain, confusion, heavy bleeding, or jaundice return.
    Mechanism: Wallet card with symptoms and emergency numbers.
    Benefits: Faster care, better outcomes.

Non-pharmacological care does not replace medical treatment or delivery; it supports it. Core medical steps are below. cme.lww.com

---

Drug Treatments

Doses below reflect common adult hospital practice; ICU teams individualize based on weight, labs, and comorbidities.

1. IV Dextrose (10–20%) – Antihypoglycemic/energy substrate
   Dose/Time: Titrate infusion to keep glucose ≥80–100 mg/dL; frequent checks.
   Purpose: Correct hypoglycemia common in AFLP.
   Mechanism: Direct glucose supply while the liver can’t maintain levels.
   Side effects: Hyperglycemia, fluid shifts, phlebitis. cme.lww.com

2. N-Acetylcysteine (NAC) – Antioxidant/hepatic support (adjunct)
   Dose: Often 150 mg/kg IV load then infusions (acetaminophen protocol, adapted per ICU).
   Purpose: Support failing hepatocytes; sometimes used in non-acetaminophen acute liver failure.
   Mechanism: Replenishes glutathione; scavenges free radicals.
   Side effects: Nausea, rare anaphylactoid reaction. (Adjunctive use is based on acute liver failure practice; team discretion.) cme.lww.com

3. Vitamin K (phytonadione) – Coagulation cofactor
   Dose: 5–10 mg IV (slow) daily as needed.
   Purpose: Help INR if deficiency contributes.
   Mechanism: Restores vitamin-K–dependent clotting factor carboxylation.
   Side effects: Rare anaphylactoid reaction IV; bruising at site.

4. Fresh Frozen Plasma (FFP) – Clotting factor replacement
   Dose: Typically 10–15 mL/kg pre-procedure or if bleeding.
   Purpose: Treat coagulopathy/bleeding and allow safe delivery or procedures.
   Mechanism: Replaces depleted clotting factors.
   Side effects: TRALI/TACO risk; infection risk is low but present. cme.lww.com

5. Cryoprecipitate (or Fibrinogen Concentrate) – Fibrinogen source
   Dose: To target fibrinogen >150–200 mg/dL if bleeding.
   Purpose: Address hypofibrinogenemia in DIC-like states.
   Mechanism: Supplies fibrinogen, vWF, factor VIII.
   Side effects: Similar to plasma products.

6. Platelet transfusion – Hemostasis support
   Dose: Common thresholds ≥50,000/µL for delivery; higher if C-section/procedures.
   Purpose: Reduce bleeding risk with thrombocytopenia.
   Mechanism: Replaces platelets.
   Side effects: Transfusion reactions.

7. Magnesium sulfate – Seizure prophylaxis (if preeclampsia overlap)
   Dose: 4–6 g IV load, then 1–2 g/hr infusion (per OB protocol).
   Purpose: Prevent eclampsia when hypertension/HELLP features present.
   Mechanism: NMDA blockade, neuroprotection.
   Side effects: Flushing, respiratory depression if high levels. UpToDate

8. Antihypertensives (e.g., Labetalol, Hydralazine) – BP control in overlap cases
   Dose: Labetalol IV 10–20 mg boluses; Hydralazine 5–10 mg IV.
   Purpose: Control severe hypertension if present.
   Mechanism: Beta/alpha blockade or arterial dilation.
   Side effects: Bradycardia (labetalol), headache/tachycardia (hydralazine). UpToDate

9. Broad-spectrum antibiotics (when infection suspected) – Sepsis control
   Dose: ICU-guided (e.g., piperacillin-tazobactam, cefepime + metronidazole) after cultures.
   Purpose: Liver failure increases infection risk; treat promptly if sepsis.
   Mechanism: Pathogen killing.
   Side effects: Drug-specific (renal, C. difficile risk).

10. Proton pump inhibitor (e.g., Pantoprazole) – Stress-ulcer prophylaxis
    Dose: 40 mg IV/PO daily.
    Purpose: Prevent GI bleeding during critical illness.
    Mechanism: Reduces gastric acid.
    Side effects: Headache; long-term risks not relevant in short ICU courses.

11. Antiemetics (ondansetron, metoclopramide) – Nausea control
    Dose: Ondansetron 4 mg IV/PO q6–8h PRN; metoclopramide 5–10 mg.
    Purpose: Reduce vomiting and aspiration risk.
    Mechanism: 5-HT3 blockade or dopamine blockade.
    Side effects: Constipation, QT caution (ondansetron); akathisia (metoclopramide).

12. Insulin (if stress hyperglycemia)
    Dose: ICU protocolized IV insulin if needed.
    Purpose: Keep glucose in safe range; although hypoglycemia is more typical, swings happen.
    Mechanism: Promotes cellular glucose uptake.
    Side effects: Hypoglycemia—tight monitoring needed.

13. Rifaximin or Lactulose (for encephalopathy)
    Dose: Lactulose 20–30 g PO/NG to 2–3 soft stools/day; Rifaximin 550 mg PO bid.
    Purpose: Lower ammonia-mediated confusion.
    Mechanism: Lactulose traps ammonia in gut; rifaximin reduces ammonia-producing bacteria.
    Side effects: Diarrhea, bloating (lactulose). (Team judgment in pregnancy/postpartum.)

14. Thiamine (Vitamin B1) – Refeeding/Wernicke protection in malnourished patients
    Dose: 100–200 mg IV daily initially, then oral.
    Purpose: Safe refeeding and brain protection if prolonged vomiting/poor intake.
    Mechanism: Cofactor for carbohydrate metabolism.
    Side effects: Very rare reactions.

15. Tranexamic acid (TXA), case-selected
    Dose: 1 g IV over 10 min, may repeat once.
    Purpose: Treat severe postpartum hemorrhage with coagulopathy (per OB protocols).
    Mechanism: Antifibrinolytic—stabilizes clots.
    Side effects: Thrombosis risk (balance risks with DIC). (OB team-led.)

Core definitive therapy is delivery + meticulous supportive care; drugs above manage complications while the liver heals after delivery. cme.lww.comThe ObG Project

---

Dietary “Molecular” Supplements

Caution: No supplement treats AFLP. These may be used post-stabilization or in deficiency states under clinician guidance.

1. Thiamine (B1) – 100–200 mg/day initially IV then PO; supports carbohydrate metabolism; prevents Wernicke in malnourished/hyperemesis patients.

2. Folate (B9) – 400–800 mcg/day PO; supports DNA synthesis and hematopoiesis; correct deficiency during recovery.

3. Riboflavin (B2) – 5–10 mg/day PO; cofactor (FAD) in fatty-acid oxidation; theoretical support for mitochondrial pathways.

4. Carnitine – 500–1,000 mg PO bid; shuttles long-chain fats into mitochondria; sometimes discussed in FAO disorders (postpartum, clinician-directed).

5. Choline – 250–500 mg/day PO; hepatocyte membrane support and VLDL export in general fatty liver physiology.

6. S-Adenosyl-L-methionine (SAMe) – 400 mg PO bid; methyl-donor for hepatic pathways; limited pregnancy-specific data.

7. Vitamin D – 1,000–2,000 IU/day PO; general immune and bone support; replete if low.

8. Selenium – 50–100 mcg/day PO; antioxidant enzymes (glutathione peroxidase); only if deficient.

9. Coenzyme Q10 – 100 mg PO daily; mitochondrial electron transport support; evidence in AFLP is theoretical.

10. Omega-3 (EPA/DHA) – 250–500 mg/day after bleeding risk subsides; inflammation modulation; avoid if bleeding risk remains high.

These are adjuncts only and should be cleared by your care team, especially if bleeding risk or procedures are planned. (Evidence in AFLP is limited; core therapy remains delivery.) The Lancet

---

Regenerative / Stem-Cell Drugs

There are no approved immune-booster, regenerative, or stem-cell drugs for AFLP. The liver typically recovers on its own after delivery with supportive care. Below are items you may read about online and why they are not recommended for AFLP, plus what clinicians use instead. cme.lww.com

1. Stem-cell infusions (MSC or others) – Experimental in chronic liver disease; not indicated in AFLP’s acute, reversible physiology.

2. Hepatocyte transplantation – Niche/experimental; not standard for AFLP; rare emergency transplant may be considered only for fulminant failure not improving after delivery.

3. “Immune boosters” (interferons, growth factors) – No role; may worsen illness or carry fetal/neonatal risks.

4. High-dose herbal “liver cleanses” – Unregulated; some herbs are hepatotoxic; avoid.

5. Growth hormone or anabolic agents – No evidence; safety concerns.

6. Platelet-rich plasma/“regenerative” IVs – No plausible benefit in hepatic micro-vesicular failure; risks outweigh any theoretical gain.

What clinicians actually escalate to when needed: ICU support, blood products, renal replacement therapy for kidney failure, liver support systems in select centers, and—very rarely—liver transplantation if the mother fails to improve after delivery. cme.lww.com

---

Procedures/Surgeries

1. Immediate delivery (induction of labor)
   Procedure: Cervical ripening + oxytocin/AROM when safe.
   Why: Definitive step—removing the pregnancy trigger allows the liver to recover. cme.lww.com

2. Cesarean section
   Procedure: Surgical delivery when induction is unsafe or too slow for maternal/fetal status.
   Why: Achieve rapid delivery in unstable cases or non-reassuring fetal status; coagulopathy must be corrected as possible. cme.lww.com

3. Emergency liver transplantation (rare)
   Procedure: Transplant team evaluation and listing; performed only if hepatic failure does not improve after delivery and meets acute liver failure criteria.
   Why: Salvage therapy for refractory fulminant failure. cme.lww.com

4. Peripartum hysterectomy (life-saving, uncommon)
   Procedure: Surgical removal of the uterus for uncontrolled postpartum hemorrhage not responsive to other measures.
   Why: DIC and severe coagulopathy can cause massive bleeding; hysterectomy can be life-saving.

5. Exploratory laparotomy / surgical hemostasis (select cases)
   Procedure: Open surgery to control intra-abdominal bleeding.
   Why: Severe coagulopathy may cause bleeding sites that require direct control.

---

Prevention Strategies

AFLP is not fully preventable, but risk and harm can be reduced through awareness and planning:

1. Early recognition education (for patients and clinicians) of red-flags: new nausea/vomiting, right-upper-quadrant pain, jaundice, intense fatigue, confusion in late pregnancy. cme.lww.com

2. Deliver in a hospital with obstetric, anesthesia, ICU, and newborn care, especially if prior AFLP or strong risk factors. cme.lww.com

3. Genetic counseling after an AFLP pregnancy: discuss FAO defects (e.g., LCHAD) and options for partner/future fetal testing. PMC

4. Plan tight clinical follow-up in third trimester; lower threshold to check labs if symptoms arise. cme.lww.com

5. Avoid prolonged fasting or crash diets late in pregnancy; keep regular meals to limit fat mobilization (general advice).

6. Prompt care for infections (they can tip fragile systems).

7. Avoid alcohol and hepatotoxic meds/herbs unless cleared by OB/hepatology.

8. Maintain vaccinations appropriate for pregnancy (per OB guidance).

9. Diabetes/gestational diabetes control to limit metabolic stress.

10. Post-AFLP “future pregnancy plan” agreed with OB/hepatology: early labs, warning-sign training, and planned delivery site. cme.lww.com

---

When to see a doctor

Call your obstetric team urgently if you are in late pregnancy or just postpartum and notice: new, persistent nausea/vomiting, right-upper-abdomen pain, yellow eyes/skin (jaundice), very dark urine or pale stools, severe fatigue, new headaches, or swelling.
Go to the emergency department now (call EMS) for confusion, fainting, severe bleeding, seizures, severe shortness of breath, or inability to keep down fluids. Early labs and monitoring save lives. cme.lww.com

---

What to eat and what to avoid

These tips apply after hospital stabilization and delivery, and always follow your team’s advice.

Eat/Do:

1. Small, frequent meals to keep sugars steady.

2. Lean proteins (eggs, poultry, legumes, dairy if tolerated) for healing.

3. Complex carbs (oats, brown rice, whole-grain bread) for steady energy.

4. Plenty of fluids, favoring water and oral rehydration if advised.

5. Colorful fruits/vegetables for vitamins and antioxidants.

Avoid/Limit:

1. Alcohol (strictly avoid).
2. Herbal “liver cleanses” or unverified supplements (risk of toxicity).
3. Very high-fat meals early in recovery if they worsen nausea/reflux.
4. Large caffeine loads if worsening reflux/sleep.
5. NSAIDs not approved by your OB (bleeding risk); ask before taking any pain reliever.

---

Frequently Asked Questions

1. Is AFLP the same as preeclampsia or HELLP?
   No. They can overlap, but AFLP is mainly micro-fat buildup and acute liver failure, while HELLP centers on hemolysis and low platelets. Many patients show features of both; clinicians treat what’s present. UpToDate

2. What confirms the diagnosis?
   Usually clinical criteria (Swansea) plus labs and imaging. Biopsy is risky and rarely required. Perinatology

3. Does delivery really fix the liver?
   In most cases, yes. Liver and clotting usually improve within 1–3 days after delivery with good ICU care, though full recovery may take longer. cme.lww.com

4. Will I need a C-section?
   The team chooses the fastest, safest route for mother and baby; sometimes induction is fine, other times a C-section is safer. cme.lww.com

5. Can the baby be affected?
   Yes—fetal distress and preterm birth can occur; quick delivery improves outcomes. Some babies may carry FAO defects; pediatric teams test and treat if needed. PMC

6. Will I have liver disease later in life?
   Most mothers do not if recovery is complete. Regular checkups are still wise. cme.lww.com

7. What about future pregnancies?
   Risk of recurrence exists, especially with underlying FAO genetics. Genetic counseling and early monitoring are recommended. PMC

8. Are steroids used?
   Magnesium and antihypertensives are used for preeclampsia overlap. Antenatal steroids for fetal lungs are considered only if time and stability allow, but delivery should not be delayed for steroids. UpToDate

9. Is NAC a cure?
   No. NAC is an adjunct borrowed from acute liver failure care; delivery remains the key step. cme.lww.com

10. Can ultrasound diagnose AFLP alone?
    Ultrasound may show bright (fatty) liver or ascites, but diagnosis is clinical + labs. Radiopaedia

11. What numbers worry doctors most?
    Low glucose, rising INR/aPTT, high bilirubin and ammonia, worsening creatinine, and worsening mental status prompt urgent action. cme.lww.com

12. Do I need a special diet forever?
    Usually no once labs normalize. Healthy, balanced eating and avoiding alcohol/herbal toxins are sensible.

13. Could this be gallbladder disease or cholestasis of pregnancy instead?
    Possibly—that’s why doctors run tests and use criteria. They rule out viral hepatitis, gallstones, cholestasis, HELLP and others. PMC

14. What complications are doctors trying to prevent?
    Bleeding/DIC, encephalopathy, kidney failure, infection, and fetal compromise. Hence the need for ICU-level monitoring and quick delivery. cme.lww.com

15. Bottom line?
    Recognize early, deliver promptly, support intensively. Most mothers recover well when these steps happen fast. The ObG Project

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 06, 2025.